Addex Therapeutics (ADXN) Enterprise Value (2020 - 2026)

Addex Therapeutics has disclosed Enterprise Value across 7 years of filings, most recently posting $4.4 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 55.41% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (up 55.41% YoY), while the FY2025 annual figure was $4.9 million, up 156.87% from the prior year.
• Enterprise Value came in at $4.4 million for Q1 2026 at Addex Therapeutics, down from $4.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $625.6 million in Q1 2022 to a low of -$612381.7 in Q4 2023.
• Average Enterprise Value over 5 years is $72.4 million, with a median of $5.0 million recorded in 2025.
• Year-over-year, Enterprise Value slumped 100.7% in 2023 and jumped 446.02% in 2025.
• Over 5 years, Enterprise Value stood at $87.7 million in 2022, then sank by 100.7% to -$612381.7 in 2023, then soared by 410.45% to $1.9 million in 2024, then jumped by 155.16% to $4.9 million in 2025, then fell by 8.66% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $4.4 million in Q1 2026, $4.9 million in Q4 2025, and $5.0 million in Q3 2025.